Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Tsontcho Ianchulev"'
Autor:
Gautam Kamthan, Thijs Meenink, Isabella C. Morgan, Andrew A. Harvey, Jorge L. Lince, Jorrit Smit, Maarten Beelen, James C. Tsai, Marc D. de Smet, Tsontcho Ianchulev
Publikováno v:
BMC Ophthalmology, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Preclinical technical feasibility study of robot-assisted microinvasive glaucoma surgery using a novel ophthalmic robot-assisted surgery system. Methods Feasibility was assessed in synthetic eye models in two stages: Stage I, noni
Externí odkaz:
https://doaj.org/article/deb08edb46d549d19f127052fc9d5d79
Autor:
Yovel Rom, Rachelle Aviv, Gal Yaakov Cohen, Yehudit Eden Friedman, Tsontcho Ianchulev, Zack Dvey-Aharon
Publikováno v:
Heliyon, Vol 10, Iss 16, Pp e36592- (2024)
Diabetes is one of the leading causes of morbidity and mortality in the United States and worldwide. Traditionally, diabetes detection from retinal images has been performed only using relevant retinopathy indications. This research aimed to develop
Externí odkaz:
https://doaj.org/article/7122fa817b3e4d929bb333eaeff865ff
Autor:
Earnest P Chen, Michael Mills, Tara Gallagher, Andrew Polis, Sophie Blasberg, Peter Pham, Ronald C Gentile, Tsontcho Ianchulev
Publikováno v:
Digital Health, Vol 9 (2023)
Introduction The unmet need for remote monitoring of visual function with home-based, patient-centric technologies became increasingly palpable during the COVID-19 pandemic. Many patients with chronic eye conditions lack access to office-based examin
Externí odkaz:
https://doaj.org/article/97b068057f3d4f74b2b8b0b99748603a
Publikováno v:
BMJ Open Ophthalmology, Vol 7, Iss 1 (2022)
Aims Diabetic retinopathy (DR) is the most common cause of vision loss in the working age. This research aimed to develop an artificial intelligence (AI) machine learning model which can predict the development of referable DR from fundus imagery of
Externí odkaz:
https://doaj.org/article/ccc7ce0865ce4696b86073763b7a7076
Publikováno v:
Therapeutic Delivery. 14:93-103
Aim: To compare pupil dilation achieved by a single microdose versus two microdoses of tropicamide-phenylephrine fixed combination (TR-PH FC) delivered by the Optejet®. Patients & methods: In this assessor-masked, crossover, noninferiority study, 60
Autor:
Tsontcho Ianchulev, Robert N Weinreb, Gautam Kamthan, Ernesto Calvo, Ravinder Pamnani, Iqbal K Ahmed
Publikováno v:
The British journal of ophthalmology.
Background/aimsTo report a first-in-human trial in open-angle glaucoma (OAG) subjects treated with a new microinterventional biostent-reinforced cyclodialysis technique to enhance supraciliary aqueous drainage.MethodsSubjects (N=10; 74.1±7.9 years o
Autor:
Idan Bressler, Rachelle Aviv, Danny Margalit, Gal Yaakov Cohen, Tsontcho Ianchulev, Shravan V. Savant, David J. Ramsey, Zack Dvey-Aharon
BackgroundDiabetic Macular Edema (DME) is a complication of diabetes which, when untreated, leads to vision loss. Screening for signs of diabetic eye disease, including DME, is recommended for all patients with diabetes at least every one to two year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8ded4a24c2c63e7d3e275040ec130df
https://doi.org/10.1101/2022.08.07.22278511
https://doi.org/10.1101/2022.08.07.22278511
Publikováno v:
Therapeutic Delivery. 12:201-214
Design: Prospective, double-masked, controlled, cross-over superiority studies. Materials & methods: Eligible volunteers in two pooled Phase III trials received microdosed mydriatics. MIST-1 study subjects received fixed-combination TR-PH, phenylephr
Publikováno v:
Therapeutic Delivery. 9:17-27
Aim: Conventional eyedropper-delivered volumes (25–50 µl) exceed the eye's usual tear-film volume (7 µl) and precorneal reservoir capacity, risking overflow and ocular/systemic complications. Piezoelectric high-precision microdosing may circumven
Autor:
David F. Chang, Iqbal Ike K. Ahmed, Richard L. Lindstrom, Robert L. Stamper, Thomas W. Samuelson, Tsontcho Ianchulev
Publikováno v:
Expert Review of Ophthalmology. 12:403-419
Introduction: Glaucoma is the leading cause of irremediable blindness worldwide. The prevalence of glaucoma will continue to increase with the increased ageing of the global population. The only way to reduce the progression of vision loss due to gla